These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 23225837)
1. Clinical evaluation of pranoprofen combined with fluorometholone eye drops on postoperative reaction of corneal cross-linking. Pang X; Fan ZJ; Peng XJ; Jia HZ; Wu TF Eye Sci; 2012 Dec; 27(4):173-7. PubMed ID: 23225837 [TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of topical pranoprofen and fluorometholone in cases with chronic allergic conjunctivitis. Li Z; Mu G; Chen W; Gao L; Jhanji V; Wang L Cornea; 2013 May; 32(5):579-82. PubMed ID: 23023407 [TBL] [Abstract][Full Text] [Related]
3. [Therapeutic effects of Pyranoprofen on the mouse dry eye induced by topical medication of Benzalkonium Chloride]. He H; Liu ZG; Lin ZR; Liu XC; He H; Xiao QG Zhonghua Yan Ke Za Zhi; 2012 Jan; 48(1):33-40. PubMed ID: 22490914 [TBL] [Abstract][Full Text] [Related]
4. Treatment of chronic nonbacterial conjunctivitis with a cyclo-oxygenase inhibitor or a corticosteroid. Pranoprofen Study Group. Notivol R; Martínez M; Bergamini MV Am J Ophthalmol; 1994 May; 117(5):651-6. PubMed ID: 8172273 [TBL] [Abstract][Full Text] [Related]
5. The Toxicity of Nonsteroidal Anti-inflammatory Eye Drops against Human Corneal Epithelial Cells in Vitro. Lee JS; Kim YH; Park YM J Korean Med Sci; 2015 Dec; 30(12):1856-64. PubMed ID: 26713063 [TBL] [Abstract][Full Text] [Related]
6. [Comparison of clinical effects of bromfenac sodium ophthalmic solution 0.1% versus glucocorticoids for post-LASEK usage]. Chen S; Jiang Y; Yu C; Li Y Zhonghua Yan Ke Za Zhi; 2015 Jan; 51(1):45-50. PubMed ID: 25877710 [TBL] [Abstract][Full Text] [Related]
7. [The clinical efficacy of 0.1% bromfenac sodium hydrate ophthalmic solution after excimer laser in situ keratomileusis]. Xu Y; Zhao X; Zhang FJ; Wang MM; Guo N; Zheng Y; Liu J; Zhang QL Zhonghua Yan Ke Za Zhi; 2013 Apr; 49(4):320-6. PubMed ID: 23900091 [TBL] [Abstract][Full Text] [Related]
8. Topical pranoprofen 0.1% is as effective anti-inflammatory and analgesic agent as diclofenac sodium 0.1% after strabismus surgery. Akyol-Salman I; Leçe-Sertöz D; Baykal O J Ocul Pharmacol Ther; 2007 Jun; 23(3):280-3. PubMed ID: 17593012 [TBL] [Abstract][Full Text] [Related]
9. Effect of the Regenerative Agent Poly(Carboxymethylglucose Sulfate) on Corneal Wound Healing After Corneal Cross-Linking for Keratoconus. Kymionis GD; Liakopoulos DA; Grentzelos MA; Tsoulnaras KI; Detorakis ET; Cochener B; Tsilimbaris MK Cornea; 2015 Aug; 34(8):928-31. PubMed ID: 26057328 [TBL] [Abstract][Full Text] [Related]
10. Effects of corneal cross-linking on ocular response analyzer waveform-derived variables in keratoconus and postrefractive surgery ectasia. Hallahan KM; Rocha K; Roy AS; Randleman JB; Stulting RD; Dupps WJ Eye Contact Lens; 2014 Nov; 40(6):339-44. PubMed ID: 25365551 [TBL] [Abstract][Full Text] [Related]
11. Non-topography-guided PRK combined with CXL for the correction of refractive errors in patients with early stage keratoconus. Fadlallah A; Dirani A; Chelala E; Antonios R; Cherfan G; Jarade E J Refract Surg; 2014 Oct; 30(10):688-93. PubMed ID: 25291752 [TBL] [Abstract][Full Text] [Related]
12. Permanent corneal haze after riboflavin-UVA-induced cross-linking in keratoconus. Raiskup F; Hoyer A; Spoerl E J Refract Surg; 2009 Sep; 25(9):S824-8. PubMed ID: 19772259 [TBL] [Abstract][Full Text] [Related]
13. Influence of glucocorticosteroids on the biomechanical properties of in-vivo rabbit cornea. Yu JG; Bao FJ; Joda A; Fu XA; Zhou S; Wang J; Hu XL; Wang QM; Elsheikh A J Mech Behav Biomed Mater; 2014 Jan; 29():350-9. PubMed ID: 24161489 [TBL] [Abstract][Full Text] [Related]
14. Long-Term Comparison of Simultaneous Topography-Guided Photorefractive Keratectomy Followed by Corneal Cross-linking versus Corneal Cross-linking Alone. Kontadakis GA; Kankariya VP; Tsoulnaras K; Pallikaris AI; Plaka A; Kymionis GD Ophthalmology; 2016 May; 123(5):974-83. PubMed ID: 26896122 [TBL] [Abstract][Full Text] [Related]
15. Complete corneal ring (MyoRing) implantation versus MyoRing implantation combined with corneal collagen crosslinking for keratoconus: 3-year follow-up. Bikbova G; Kazakbaeva G; Bikbov M; Usubov E Int Ophthalmol; 2018 Jun; 38(3):1285-1293. PubMed ID: 28620706 [TBL] [Abstract][Full Text] [Related]
16. Steroid-induced ocular hypertension in the pediatric age group. Al Hanaineh AT; Hassanein DH; Abdelbaky SH; El Zawahry OM Eur J Ophthalmol; 2018 Jul; 28(4):372-377. PubMed ID: 29554813 [TBL] [Abstract][Full Text] [Related]
17. Comparison of sequential vs same-day simultaneous collagen cross-linking and topography-guided PRK for treatment of keratoconus. Kanellopoulos AJ J Refract Surg; 2009 Sep; 25(9):S812-8. PubMed ID: 19772257 [TBL] [Abstract][Full Text] [Related]
18. Transient corneal thinning in eyes undergoing corneal cross-linking. Holopainen JM; Krootila K Am J Ophthalmol; 2011 Oct; 152(4):533-6. PubMed ID: 21726844 [TBL] [Abstract][Full Text] [Related]
19. Clinical observation of transepithelial corneal collagen cross-linking by lontophoresis of riboflavin in treatment of keratoconus. Li N; Fan Z; Peng X; Pang X; Tian C Eye Sci; 2014 Sep; 29(3):160-4. PubMed ID: 26011972 [TBL] [Abstract][Full Text] [Related]
20. Corneal Collagen Cross-Linking in the Treatment of Progressive Keratoconus: A Randomized Controlled Contralateral Eye Study. Seyedian MA; Aliakbari S; Miraftab M; Hashemi H; Asgari S; Khabazkhoob M Middle East Afr J Ophthalmol; 2015; 22(3):340-5. PubMed ID: 26180474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]